Cargando…

Protocol for the development of a core domain set for individuals with ankle osteoarthritis

BACKGROUND: Ankle osteoarthritis (OA) is a debilitating health condition that is increasing in prevalence. Currently, there are no evidence-based guidelines for managing ankle OA. One of the current challenges to establishing guidelines is the lack of a widely agreed-upon set of outcome measures tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazi, Sultan Ayyadah, Vicenzino, Bill, van Bergen, Christiaan J. A., Hunter, David J., Wikstrom, Erik A., Menz, Hylton B., Golightly, Yvonne M., Smith, Michelle D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446870/
https://www.ncbi.nlm.nih.gov/pubmed/36064628
http://dx.doi.org/10.1186/s13063-022-06692-0
_version_ 1784783734669574144
author Alanazi, Sultan Ayyadah
Vicenzino, Bill
van Bergen, Christiaan J. A.
Hunter, David J.
Wikstrom, Erik A.
Menz, Hylton B.
Golightly, Yvonne M.
Smith, Michelle D.
author_facet Alanazi, Sultan Ayyadah
Vicenzino, Bill
van Bergen, Christiaan J. A.
Hunter, David J.
Wikstrom, Erik A.
Menz, Hylton B.
Golightly, Yvonne M.
Smith, Michelle D.
author_sort Alanazi, Sultan Ayyadah
collection PubMed
description BACKGROUND: Ankle osteoarthritis (OA) is a debilitating health condition that is increasing in prevalence. Currently, there are no evidence-based guidelines for managing ankle OA. One of the current challenges to establishing guidelines is the lack of a widely agreed-upon set of outcome measures that are consistently used in ankle OA research. Without a set of agreed-upon outcome measures, it is difficult to synthesise clinical trial outcomes through meta-analysis—an essential element of evidence-informed practice. In order to develop an appropriate set of outcome measures for ankle OA, it is important first to develop a core domain set. In this protocol, we describe the methodological approach that we will use to develop such a core domain set for ankle OA. METHODS: We established an international steering committee to guide the development of a core domain set for ankle OA. The core domain set development will follow a multi-staged approach consisting of three phases, involving participation by patients and clinicians/healthcare professionals. In phase 1, a list of candidate domains will be gleaned from (a) a scoping review of outcome measures used in ankle OA research, (b) qualitative interviews with individuals with ankle OA, and (c) qualitative interviews with healthcare professionals with expertise in ankle OA. In phase 2, the steering committee will review and generate a list of candidate domains from those gleaned in phase 1. In phase 3, this list of candidate domains will be considered in a Delphi process to reach a consensus on a core domain set. We anticipated this will involve 3 rounds of surveys. CONCLUSION: This protocol describes the methods that will be used to develop a core domain set of health-related aspects for ankle OA. Importantly, it will include both healthcare professional and patient involvement. This is a prerequisite step to developing a core outcome set for ankle OA that should be reported in all clinical trials for ankle OA. The findings will be widely disseminated across peer-refereed publication(s) and national and international conferences, as well as via relevant professional societies, patient support group organisations, and social media platforms. PROJECT REGISTRATION: This project is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database on 17 March 2021. https://www.comet-initiative.org/Studies/Details/1837. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06692-0.
format Online
Article
Text
id pubmed-9446870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94468702022-09-07 Protocol for the development of a core domain set for individuals with ankle osteoarthritis Alanazi, Sultan Ayyadah Vicenzino, Bill van Bergen, Christiaan J. A. Hunter, David J. Wikstrom, Erik A. Menz, Hylton B. Golightly, Yvonne M. Smith, Michelle D. Trials Study Protocol BACKGROUND: Ankle osteoarthritis (OA) is a debilitating health condition that is increasing in prevalence. Currently, there are no evidence-based guidelines for managing ankle OA. One of the current challenges to establishing guidelines is the lack of a widely agreed-upon set of outcome measures that are consistently used in ankle OA research. Without a set of agreed-upon outcome measures, it is difficult to synthesise clinical trial outcomes through meta-analysis—an essential element of evidence-informed practice. In order to develop an appropriate set of outcome measures for ankle OA, it is important first to develop a core domain set. In this protocol, we describe the methodological approach that we will use to develop such a core domain set for ankle OA. METHODS: We established an international steering committee to guide the development of a core domain set for ankle OA. The core domain set development will follow a multi-staged approach consisting of three phases, involving participation by patients and clinicians/healthcare professionals. In phase 1, a list of candidate domains will be gleaned from (a) a scoping review of outcome measures used in ankle OA research, (b) qualitative interviews with individuals with ankle OA, and (c) qualitative interviews with healthcare professionals with expertise in ankle OA. In phase 2, the steering committee will review and generate a list of candidate domains from those gleaned in phase 1. In phase 3, this list of candidate domains will be considered in a Delphi process to reach a consensus on a core domain set. We anticipated this will involve 3 rounds of surveys. CONCLUSION: This protocol describes the methods that will be used to develop a core domain set of health-related aspects for ankle OA. Importantly, it will include both healthcare professional and patient involvement. This is a prerequisite step to developing a core outcome set for ankle OA that should be reported in all clinical trials for ankle OA. The findings will be widely disseminated across peer-refereed publication(s) and national and international conferences, as well as via relevant professional societies, patient support group organisations, and social media platforms. PROJECT REGISTRATION: This project is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database on 17 March 2021. https://www.comet-initiative.org/Studies/Details/1837. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06692-0. BioMed Central 2022-09-05 /pmc/articles/PMC9446870/ /pubmed/36064628 http://dx.doi.org/10.1186/s13063-022-06692-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Alanazi, Sultan Ayyadah
Vicenzino, Bill
van Bergen, Christiaan J. A.
Hunter, David J.
Wikstrom, Erik A.
Menz, Hylton B.
Golightly, Yvonne M.
Smith, Michelle D.
Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title_full Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title_fullStr Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title_full_unstemmed Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title_short Protocol for the development of a core domain set for individuals with ankle osteoarthritis
title_sort protocol for the development of a core domain set for individuals with ankle osteoarthritis
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446870/
https://www.ncbi.nlm.nih.gov/pubmed/36064628
http://dx.doi.org/10.1186/s13063-022-06692-0
work_keys_str_mv AT alanazisultanayyadah protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT vicenzinobill protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT vanbergenchristiaanja protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT hunterdavidj protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT wikstromerika protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT menzhyltonb protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT golightlyyvonnem protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis
AT smithmichelled protocolforthedevelopmentofacoredomainsetforindividualswithankleosteoarthritis